NASDAQ:ALKS
Alkermes plc Stock News
$24.26
+0.160 (+0.664%)
At Close: May 09, 2024
Multiple Sclerosis Drugs Industry Assessment 2020: Immunomodulators, Immunosuppressants, Interferons and Others
02:45pm, Tuesday, 21'st Apr 2020
The "Multiple Sclerosis Drugs Market Global Report 2020" report has been added to ResearchAndMarkets.com's offering.
Nuveen Asset Management LLC Purchases 94,688 Shares of Alkermes Plc (NASDAQ:ALKS)
11:41am, Sunday, 19'th Apr 2020
Nuveen Asset Management LLC lifted its position in Alkermes Plc (NASDAQ:ALKS) by 25.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC
The "Multiple Sclerosis Drugs Market Global Report 2020" report has been added to ResearchAndMarkets.com's offering.
Alkermes (ALKS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
04:31pm, Thursday, 16'th Apr 2020
Alkermes (ALKS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Alkermes (ALKS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
04:31pm, Thursday, 16'th Apr 2020
Alkermes (ALKS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Alkermes Plc (NASDAQ:ALKS) Short Interest Update
06:08am, Thursday, 16'th Apr 2020
Alkermes Plc (NASDAQ:ALKS) was the recipient of a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 7,970,000 shares, an increase of 23.4% fr
Alkermes (ALKS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
12:00am, Thursday, 16'th Apr 2020Norges Bank Takes $33.05 Million Position in Alkermes Plc (NASDAQ:ALKS)
10:44am, Tuesday, 14'th Apr 2020
Norges Bank bought a new stake in Alkermes Plc (NASDAQ:ALKS) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund
Alkermes Plc (NASDAQ:ALKS) Given Average Recommendation of "Hold" by Brokerages
11:54am, Monday, 13'th Apr 2020
Alkermes Plc (NASDAQ:ALKS) has been given a consensus recommendation of “Hold” by the seventeen ratings firms that are currently covering the company, Marketbeat Ratings reports. Two analysts have
Bank of New York Mellon Corp Sells 74,534 Shares of Alkermes Plc (NASDAQ:ALKS)
09:06am, Saturday, 11'th Apr 2020
Bank of New York Mellon Corp trimmed its holdings in Alkermes Plc (NASDAQ:ALKS) by 11.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 558,311
Should You Worry About Alkermes plc’s (NASDAQ:ALKS) CEO Pay?
10:06am, Friday, 10'th Apr 2020
Richard Pops has been the CEO of Alkermes plc (NASDAQ:ALKS) since 2011. First, this article will compare CEO...
Geode Capital Management LLC Trims Stake in Alkermes Plc (NASDAQ:ALKS)
09:54am, Friday, 10'th Apr 2020
Geode Capital Management LLC trimmed its holdings in shares of Alkermes Plc (NASDAQ:ALKS) by 0.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Excha
New York, April 08, 2020 -- Reportlinker.com announces the release of the report "Controlled Release Drug Delivery Market Size, Share & Trends Analysis Report By.
